The CRLB provides high-quality storage facilities for biological samples. Presently, there are more than 3 million samples stored in nitrogen vapour at-160 to -190°C.
Collected samples in the Biobank are linked to relevant clinical information and enable investigation of novel questions relating to diabetes, obesity, cardiovascular disease, hypertension, stroke, kidney disease, fractures and cancer.
Current collaborations include: a European Union funded consortium, SysKid, which examines the role of genetics in the development of chronic kidney disease in individuals with diabetes from the ONTARGET/TRANSCEND studies; the interaction of the environment and lipid levels in the PURE study; markers for acute myocardial infarction, stroke and kidney disease during surgery, bioVISION; and the clinical significance of Lp(a) in the INTERHEART study using insights provided through genetic and biochemical investigations.
The CRLB provides biological sample storage and other support for the CHILD (Canadian Healthy Infant Longitudinal Development) study, which involves a collaboration of pediatric hospitals across Canada.
Laboratory investigations have been funded by peer-reviewed grants from Canada, the US, the European Community, as well as the pharmaceutical and diagnostics industries.
The CRLB welcomes opportunities for partnership and collaboration.